MX172916B - Procedimiento para la obtencion de preparados vitaminicos - Google Patents

Procedimiento para la obtencion de preparados vitaminicos

Info

Publication number
MX172916B
MX172916B MX159456A MX15945675A MX172916B MX 172916 B MX172916 B MX 172916B MX 159456 A MX159456 A MX 159456A MX 15945675 A MX15945675 A MX 15945675A MX 172916 B MX172916 B MX 172916B
Authority
MX
Mexico
Prior art keywords
procedure
percent
vitamin
vitamin preparations
obtaining vitamin
Prior art date
Application number
MX159456A
Other languages
English (en)
Inventor
Rene Josse
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX172916B publication Critical patent/MX172916B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a un procedimiento para la obtención de preparados vitamínicos, cuyo procedimiento comprende mezclar entre sí alrededor de 20-55 porciento de propinato de vitamina A, opcionalmente la combinación con vitamina D y/o vitamina E, alrededor de 10-30 porciento de un emulgente no iónico, alrededor de 5-45 porcirnto de un agente solubilizante y alrededor de 5-15 porciento de un isopropanol.
MX159456A 1975-02-14 1975-07-07 Procedimiento para la obtencion de preparados vitaminicos MX172916B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH189775 1975-02-14

Publications (1)

Publication Number Publication Date
MX172916B true MX172916B (es) 1994-01-20

Family

ID=4221142

Family Applications (1)

Application Number Title Priority Date Filing Date
MX159456A MX172916B (es) 1975-02-14 1975-07-07 Procedimiento para la obtencion de preparados vitaminicos

Country Status (11)

Country Link
US (1) US4075333A (es)
JP (1) JPS603044B2 (es)
BE (1) BE831363A (es)
CA (1) CA1043258A (es)
DE (1) DE2526938C2 (es)
ES (1) ES439106A1 (es)
FR (1) FR2300554A1 (es)
GB (1) GB1471797A (es)
MX (1) MX172916B (es)
NL (1) NL167092C (es)
ZA (1) ZA754011B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048000A1 (de) * 1980-12-19 1982-07-15 Basf Ag Stabile injizierbare (beta)-carotin-solubilisate und verfahren zu ihrer herstellung
US4308264A (en) * 1981-01-28 1981-12-29 Abbott Laboratories Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration
HU185533B (en) * 1982-05-21 1985-02-28 Richter Gedeon Vegyeszet Process for producing concentrated hydrosoles containing h lipophilic and hydrophilic vitamines
DE3241113A1 (de) * 1982-11-06 1984-05-10 Bayer Ag, 5090 Leverkusen Vakzinen mit zuschlagstoffen
ATE55056T1 (de) * 1982-12-09 1990-08-15 Advanced Drug Tech Einfach absorbierbare fettsaeureemulsionen.
US4612194A (en) * 1984-02-15 1986-09-16 Roshdy Ismail Anti-rheumatic agents and their use
US4572915A (en) * 1984-05-01 1986-02-25 Bioglan Laboratories Clear micellized solutions of fat soluble essential nutrients
US4784845A (en) * 1985-09-16 1988-11-15 American Cyanamid Company Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs
JPS62106018A (ja) * 1985-11-01 1987-05-16 Santen Pharmaceut Co Ltd 高濃度ビタミンｅ水性製剤
DE4031094A1 (de) * 1990-10-02 1992-04-09 Basf Ag Verfahren zur herstellung von stabilen injizierbaren (beta)-carotin-solubilisaten
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
US6011062A (en) * 1994-12-22 2000-01-04 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
KR19990071255A (ko) * 1998-02-28 1999-09-15 성재갑 소마토트로핀과 비타민의 합제 조성물
AUPR549901A0 (en) * 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
WO2002040034A1 (en) * 2000-11-14 2002-05-23 Vital Health Sciences Pty Ltd. Complexes of phosphate derivatives
US6774100B2 (en) 2000-12-06 2004-08-10 Imaginative Research Associates, Inc. Anhydrous creams, lotions and gels
US6462025B2 (en) 2000-12-12 2002-10-08 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
WO2002076442A1 (fr) * 2001-03-27 2002-10-03 Santen Pharmaceutical Co., Ltd. Preparation liquide aqueuse stable
JP4745608B2 (ja) * 2001-07-27 2011-08-10 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 電子伝達剤のリン酸誘導体を用いた皮膚治療
US7081248B2 (en) * 2001-08-03 2006-07-25 Adisseo France S.A.S. Concentrated water-dispersible vitamin compositions
JP2005515996A (ja) * 2001-12-03 2005-06-02 ノバセア インコーポレイティッド 活性型ビタミンｄ化合物を含む薬学的組成物
DE60238276D1 (de) * 2001-12-13 2010-12-23 Vital Health Sciences Pty Ltd Transdermaler transport von verbindungen
AU2002950713A0 (en) * 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20050026877A1 (en) * 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
JP4690305B2 (ja) * 2003-01-17 2011-06-01 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 抗増殖性質を有する化合物
AU2003901815A0 (en) * 2003-04-15 2003-05-01 Vital Health Sciences Pty Ltd Phosphate derivatives
US20060189586A1 (en) * 2003-06-11 2006-08-24 Cleland Jeffrey L Pharmaceutical compositions comprising active vitamin D compounds
US20050020546A1 (en) * 2003-06-11 2005-01-27 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
CA2557354C (en) 2004-03-03 2013-05-07 Vital Health Sciences Pty Ltd. Alkaloid formulations
RU2435580C2 (ru) * 2005-03-03 2011-12-10 Вайтал Хэлф Сайнсис Пти Лтд Составы, обладающие антиканцерогенными свойствами
JP5221343B2 (ja) * 2005-06-17 2013-06-26 バイタル ヘルス サイエンシズ プロプライアタリー リミティド 担体
RU2008123556A (ru) * 2005-12-23 2010-01-27 Вайтал Хэлф Сайнсис Пти Лтд (Au) Составы, имеющие цитокин модулирующие свойства
AU2007263783B2 (en) 2006-06-27 2011-11-17 Akzo Nobel N.V. Formulations comprising a vitamin and the use thereof to make fortified feed and personal care formulations
AU2011213557B2 (en) 2010-02-05 2015-05-07 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
RU2553350C2 (ru) 2010-03-30 2015-06-10 Фосфейдженикс Лимитед Трансдермальные пластыри
EP2685992A4 (en) 2011-03-15 2014-09-10 Phosphagenics Ltd AMINO-QUINOLINES AS KINASE INHIBITORS
WO2016188874A1 (en) * 2015-05-22 2016-12-01 Fresenius Kabi Deutschland Gmbh Vitamin a for parenteral administration
EP3297604B1 (en) * 2015-05-22 2020-07-22 Fresenius Kabi Deutschland GmbH Vitamin a for parenteral administration
CN108601732A (zh) 2015-12-09 2018-09-28 磷肌酸有限公司 药物制剂
US20190330260A1 (en) 2016-12-21 2019-10-31 Avecho Biotechnology Limited Process

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3070499A (en) * 1960-09-19 1962-12-25 Merck & Co Inc Parenteral aqueous solutions of fat soluble vitamins
US3149037A (en) * 1962-09-07 1964-09-15 Hoffmann La Roche Vitamin compositions
FR1370929A (fr) * 1963-09-06 1964-08-28 Hoffmann La Roche Procédé pour la préparation de compositions vitaminées
US3244595A (en) * 1965-05-07 1966-04-05 Mattox And Moore Inc Composition for administering vitamins a, d, and e
DE2019839A1 (de) * 1969-04-28 1970-11-05 Ferrosan As Stabile,klare,wasserdispergierbare bzw.-verduennbare,Vitamin-A enthaltende Loesung und Verfahren zu ihrer Herstellung
US3639587A (en) * 1969-11-07 1972-02-01 Eastman Kodak Co Medicinal compositions for administration to animals and process for administering same
US3708583A (en) * 1970-04-03 1973-01-02 Vitamin Premixers Of Omaha Inc Stabilized vitamin a additive
NL7012460A (es) 1970-08-22 1972-02-24
US3932634A (en) * 1973-06-28 1976-01-13 Pfizer Inc. High potency vitamin water dispersible formulations

Also Published As

Publication number Publication date
DE2526938C2 (de) 1982-04-22
NL7508437A (nl) 1976-08-17
FR2300554A1 (fr) 1976-09-10
DE2526938A1 (de) 1976-08-26
NL167092C (nl) 1981-11-16
JPS603044B2 (ja) 1985-01-25
FR2300554B1 (es) 1979-10-12
JPS5195123A (en) 1976-08-20
CA1043258A (en) 1978-11-28
NL167092B (nl) 1981-06-16
AU8249875A (en) 1977-01-06
ES439106A1 (es) 1977-07-01
GB1471797A (en) 1977-04-27
US4075333A (en) 1978-02-21
BE831363A (fr) 1976-01-15
ZA754011B (en) 1976-09-29

Similar Documents

Publication Publication Date Title
MX172916B (es) Procedimiento para la obtencion de preparados vitaminicos
IT7830205A0 (it) Derivati di 1,3,4,5-tetraidrobenz-indolo erelativo procedimento per fabbricarli.
NL7713091A (nl) Derivaten van de trypsine-callicreine-remmer uit runderorganen (bpti) met proteasen remmende werking en antiflogistische werking, alsmede de bereiding van dergelijke derivaten en preparaten, die deze derivaten bevatten.
ES486327A0 (es) Procedimiento para la fabricacion de un objeto que consiste en al menos dos partes movibles relativamente entre si par- ticularmente para cojinetes antifriccion.
NL183413B (nl) Werkwijze voor de bereiding van koolstofstaal of laag gelegeerd staal.
SE7707853L (sv) Modifierade polyoler
ES470088A3 (es) Un procedimiento para la preparacion de una composicion liquida, semiliquida o gelificada, util en el cuidado de la piel
NL7606093A (nl) Werkwijze voor de microbiologische oxydatie van steroiden.
BR8008976A (pt) Conjunto tubular, metodo de preparacao do conjunto, aparelho para vazamento pelo fundo que incorpora o conjunto e metodo de fundicao de metal
SE7611952L (sv) Forfarande for framstellning av aroyl-fenylinden- och aroyl-fenylnaftalenderivat anvendbara sasom antifertilitetsmedel
NL7609313A (nl) Gesubstitueerde 2-fenylimino-1,3-dithiolanen, werkwijze voor het bereiden ervan alsmede toe- passing ervan als ectoparasiticide middel.
IS2014A7 (is) Aðferð við beitningu lína (lóð) og fyrirkomulag til aða framkvæma aðferðina.
NL7602147A (nl) Werkwijze voor de bereiding van legeringen.
ES452943A1 (es) Procedimiento para preparar 1,2,3,4-tetrahidro-4-oxo-1-naf- tilisocianato e isotiocianato.
ES2138215T3 (es) Metodo para eliminar un color no deseado de acido clorhidrico.
ES474052A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas 1-n-sustituidas.
IT1054567B (it) Mezzi e metodo per la riparazione di valvole
JPS51133116A (en) A method and apparatus for cooling of metal strips
JPS5241218A (en) Method of producing diagnostic agent for neoplasm
NL7603227A (nl) Werkwijze ter bereiding van een optisch actief (alpha)-fenylglycine en tussenprodukten daarvan.
SU43274A1 (ru) Способ обработки асбестового волокна
SU605650A1 (ru) Способ прокатки труб на редукционном стане
JPS52129275A (en) Impurity diffusion method
NL7710638A (nl) Glasvezel(s), voorzien van een appreteermiddel en werkwijze voor de bereiding van een derge- lijk appreteermiddel.
JPS5223517A (en) Wire for weld wire mesh